Healthcare101

 The global  Molecular Diagnostics Market , valued at US$18.29 billion in 2024, stood at US$19.48 billion in 2025 and is projected to advance at a resilient CAGR of 9.6% from 2025 to 2030, culminating in a forecasted valuation of US$30.74 billion by the end of the period. Increased government funding in precision medicine and genomics has boosted the adoption of molecular diagnostic kits and instruments. Furthermore, the rising prevalence of infectious diseases and cancer is playing a significant role in driving market expansion. Additionally, the growing number of hospitals in developed and emerging regions, driven by an increasing patient population, is further fueling the demand for accurate molecular testing. Moreover, recent technological advancements, particularly in portability and rapid turnaround times, have made it easier for smaller healthcare facilities to incorporate molecular-based testing into their workflows. Download PDF Broc...

 Endoscopy equipment plays a critical role in modern healthcare by enabling physicians to visualize internal organs and body cavities with minimal invasiveness. From early disease detection to complex therapeutic procedures, endoscopy has transformed diagnostics, surgery, and patient outcomes across multiple medical specialties. The endoscopy equipment market is projected to reach USD 53.54 billion by 2030 from USD 37.08 billion in 2025, at a CAGR of 7.6% during the forecast period. What Is Endoscopy? Endoscopy is a medical procedure that uses specialized instruments to examine the interior of the body through natural openings or small incisions. The procedure relies on endoscopy equipment , which includes scopes, imaging systems, light sources, and accessory instruments. 👉 In simple terms: Endoscopy allows doctors to see, diagnose, and treat conditions inside the body without open surgery. Download Sample PDF: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=...

 The global healthcare information exchange (HIE) market , valued at US$1.5 billion in 2023 , rose to US$1.7 billion in 2024 and is projected to advance at a robust CAGR of 10.2% from 2024 to 2029 , reaching an estimated US$2.8 billion by the end of the forecast period. This growth underscores the increasing importance of seamless data sharing, interoperability, and digitization in modern healthcare systems. The comprehensive research on this market includes an in-depth analysis of pricing trends, patent activity, technological innovations, and strategic initiatives shaping the global HIE ecosystem. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249987292 Key Growth Drivers The expansion of the healthcare information exchange market is primarily driven by the increasing emphasis on population health management , value-based care models , and regulatory mandates promoting electronic health record (EHR) adoption. Additionally, governments an...

  Market Overview The preimplantation genetic testing (PGT) market is experiencing substantial growth, driven by the increasing demand for genetic screening during in vitro fertilization (IVF) procedures. PGT involves analyzing embryos for genetic abnormalities before implantation, allowing clinicians to select healthy embryos for transfer, thereby increasing the chances of successful pregnancy and reducing the risk of genetic disorders in offspring. The global preimplantation genetic testing market is projected to grow from USD 690.2 million in 2025 to USD 1,135.0 million by 2030, at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2030. This growth is attributed to several factors, including: Increasing Awareness of Genetic Disorders: Growing awareness among couples about the risk of transmitting genetic disorders to their children is driving the demand for PGT. Advancements in Technology: Technological advancements in PGT techniques, su...

 The global urology devices market continues to gain momentum as the demand for advanced diagnostic, therapeutic, and minimally invasive solutions rises across healthcare systems. Valued at USD 35.56 billion in 2025 , the market is projected to reach USD 46.26 billion by 2030 , reflecting a steady CAGR of 6.0% during the forecast period. This growth is rooted in rising urological disorders, expanding aging populations, and rapid technological innovation. Download PDF Brochure Why the Urology Devices Market Is Growing 1. Rising Prevalence of Urological Conditions Kidney stones, urinary incontinence, benign prostatic hyperplasia (BPH), pelvic organ prolapse, and urologic cancers are increasing globally. Lifestyle factors, dehydration, obesity, and aging contribute significantly to the growing patient pool, boosting demand for effective diagnosis and treatment devices. 2. Increasing Adoption of Minimally Invasive Procedures Patients and clinicians are increasingly shifti...

 The global biopharmaceutical contract manufacturing market , valued at US$20.51 billion in 2024 , stood at US$22.40 billion in 2025 and is projected to grow at a CAGR of 8.8% from 2025 to 2030, reaching a forecasted US$34.15 billion by 2030 . This robust growth reflects the rising global demand for outsourcing services, fueled by increasing biologics and biosimilars production, as well as the expanding prevalence of chronic and rare diseases. However, the market faces certain barriers related to intellectual property (IP) rights and compliance with stringent regulatory frameworks. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163964739 Attractive Opportunities in the Biopharmaceutical Contract Manufacturing Market The biopharmaceutical contract manufacturing market presents strong opportunities across multiple regions, with Asia Pacific emerging as a particularly attractive hub. The growth of the Asia Pacific market is driven by: ...

 In modern medicine, diagnostics are rapidly moving toward less invasive, more precise, and real-time approaches . One of the most transformative innovations driving this change is liquid biopsy —a technique that is reshaping how diseases, especially cancer, are detected and monitored. The liquid biopsy market is estimated at USD 4.03 billion in 2025 and is projected to reach USD 7.05 billion by 2030, growing at a CAGR of 11.8% during the forecast period.  📌 What Is a Liquid Biopsy? A liquid biopsy is a diagnostic test that analyzes biological markers found in body fluids—most commonly blood—to gather information about a disease. 👉 In simple terms: Instead of surgically removing tissue, doctors can “read” disease signals from a blood sample. These signals may include: Circulating tumor DNA ( ctDNA ) Circulating tumor cells ( CTCs ) Cell-free DNA ( cfDNA ) RNA, proteins, or exosomes Download PDF Brochure: https://www.marketsa...